Pune: KEM Hospital, Pune successfully conducted the Handing Over Ceremony of the newly installed HPLC Variant II Machine on 24th November 2025. This advanced diagnostic system has been generously donated by Finolex Industries Ltd. to support and strengthen the hospital’s services in the diagnosis of Haemoglobinopathy and Thalassemia.
Haemoglobin disorders remain a major public health concern in India, affecting infants, children, adolescent girls, and pregnant women. The Department of Pathology at KEM Hospital has been providing Haemoglobin Electrophoresis testing for over two decades at an affordable cost, ensuring access to early detection and timely patient management.
Shirin Wadia, CEO of KEM Hospital, Pune, said, “The installation of the HPLC Variant II Machine is a significant milestone in our commitment to fight haemoglobin disorders. With this advanced technology and the generous support of Finolex Industries Ltd., we are now better equipped to provide timely, accurate, and affordable diagnosis for those who need it most.”
She added that Finolex Industries and the Mukul Madhav Foundation have been valued partners of KEM Hospital for over two decades, supporting paediatrics, OPD, neonatal care, and several other departments under the guidance of Late Dr. Anand Pandit. She noted that MMF’s long-standing commitment and timely support have greatly contributed to the continuous upgradation of services at KEM Hospital, strengthening patient care year after year.
Dr Rama Manchanda, Haematologist, KEM hospital said – we are very grateful to MMF for helping us to diagnose hemoglobinapathies. With the help of this machine in our population this will go a long way to diagnose the carriers of these disorders like thalassemia which will prevent the birth of thalassemia major cases and reduce the socio economic burden of the family as well as the society.
“Our mission has always been to ensure that quality healthcare reaches every individual, regardless of their background. This contribution is a step toward securing a healthier future for countless families. We are proud to partner with KEM Hospital in strengthening diagnostic services that can transform early care and outcomes for patients with haemoglobin disorders. Over the years, FIL–MMF has been deeply committed to supporting children living with Thalassemia by providing medical filters, medicines, and continuous care to over 300 children every month. We have also prioritised prevention through our state-wide Thalassemia and Diabetes awareness initiatives in colleges across Maharashtra and Gujarat. By combining improved diagnostics with sustained community awareness, we hope to reduce the burden of genetic disorders and empower the next generation with knowledge and timely intervention.” said Ritu Prakash Chhabria, Managing Trustee, Mukul Madhav Foundation.
This initiative reinforces the shared commitment of KEM Hospital and Finolex Industries Ltd. toward improving community health and expanding access to critical medical services through the many initiatives we undertake together. It also reflects the collective mission of FIL–MMF and KEM Hospital to continuously upgrade healthcare infrastructure, strengthen diagnostic and treatment capacities, and ensure that high-quality, affordable care reaches every section of society.
